On average, during the first year, those taking lorcaserin lost around 5.449 kg, while those taking the placebo lost around 2.2 kg

Appropriate use: During significant shortages or when branded medications are unattainable When a patient has a documented allergy or intolerance to an inactive ingredient in the FDA-approved product When a clinically justified dose or formulation is not commercially available for example, micro-dosing or alternative administration When a patient faces financial barriers and no affordable FDA-approved options are available, with documented clinical oversight and informed consent Inappropriate use: Simply for convenience or general cost-cutting without exploring other available, safer options For widespread, elective use without individualized clinical justification When used as a first-line alternative in place of available FDA-approved medications Decision-making checklist for employers: Confirm PCAB or equivalent pharmacy accreditation Require third-party testing for purity, potency, and sterility Clarify 503A vs

Its signaling to the pancreas to make more insulin because the blood sugars are elevated, and that helps to overcome that resistance
The medication is a biological molecule, a peptide, and peptides are sensitive to temperature, light, and physical agitation
Here is a comparison of the starting approaches